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Abstract
Background: In healthcare facilities, Clostridium difficile infections spread by transmission of bacterial spores.
Appropriate sporicidal disinfectants are needed to prevent development of clusters and outbreaks. In this study
different cleaning/disinfecting wipes and sprays were tested for their efficacy against spores of distinctive C. difficile
PCR ribotypes.
Methods: Four different products were tested; 1) hydrogen peroxide 1.5%; 2) glucoprotamin 1.5%; 3) a mixture of
ethanol, propane and N-alkyl amino propyl glycine; and 4) a mixture of didecyldimonium chloride, benzalkonium
chloride, polyaminopropyl, biguanide and dimenthicone as active ingredients. Tiles were contaminated with a
test solution containing a concentration of 5x106CFU/ml spores of C. difficile strains belonging to PCR ribotypes
010, 014 or 027. The tiles were left to dry for an hour and then wiped or sprayed with one of the sprays or wipes as
intended by the manufacturers. When products neutralized after 5 min, microbiological cultures and ATP measures
were performed.
Results: Irrespective of the disinfection method, the microbial count log10 reduction of C. difficile PCR ribotype 010
was highest, followed by the reduction of C. difficile 014 and C. difficile 027. Overall, the wipes performed better
than the sprays with the same active ingredient. On average, although not significantly, a difference in relative light
units (RLU) reduction between the wipes and sprays was found. The wipes had a higher RLU log10 reduction, but
no significant difference for RLU reduction was observed between the different C. difficile strains (p = 0.16).
Conclusion: C. difficile spores of PCR ribotypes 014 and 027 strains are more difficult to eradicate than non-toxigenic
PCR ribotype 010. In general, impregnated cleaning/disinfection wipes performed better than ready-to-use sprays.
Wipes with hydrogen peroxide (1.5%) showed the highest bactericidal activity.
Keywords: Cleaning/disinfecting wipes, Cleaning/disinfecting sprays, C. difficile, ATP, CFU
Background
Currently C. difficile is emerging worldwide in health-
care facilities [1]. The incidence of C. difficile infections
doubled between 2001 and 2010 in the United States of
America [2–5]. C. difficile is an important health threat
associated with morbidity, mortality, and extra costs.
The costs caused by C. difficile are estimated between
$8911 and $30,049 per case [3, 5]. These costs arise due
to direct healthcare costs and due to longer hospital
stays. The yearly national excess hospital cost associated
with hospital-onset C. difficile is estimated to be €4 billion
for Europe, $1 billion in the United States of America and
$280 million in Canada [5, 6]. Effective infection control
measures are therefore greatly needed.
The hospital environment is known to be a key path-
way for patients to acquire C. difficile infections (CDI).
Spores of C. difficile can survive in hospitals for years
[7]. New views on the transmission of C. difficile con-
clude that asymptomatic carriers can also introduce the
bacteria into the hospital and may consequently play an
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important part in the transmission to other patients.
Still, the chance of transmission from asymptomatic car-
riers is probably lower than from patients with a CDI [8, 9].
Guidelines to date only advise to take extra measures with
CDI diagnosed patients, for example the guideline for disin-
fection and sterilization in healthcare facilities, 2008, of the
Centers of Disease Control and Prevention (CDC).
To disinfect environments contaminated with C. diffi-
cile, it is generally advised to use an unbuffered 1:10 di-
lution of hypochlorite [10]. It is known that hypochlorite
does not enhance sporulation and when used for envir-
onmental disinfection leads to a significant reduction of
C. difficile-associated diarrhea [11]. However, hypochlor-
ite has to be used in excessive concentrations to be ef-
fective, thereby increasing its toxic and corrosive
properties. Therefore, alternative agents are needed to
eradicate spores of C. difficile.
In the present study, four products were tested that
are most commonly used as cleaning and disinfecting
products in hospitals in the Netherlands. These products
were tested for their efficacy against three different C.
difficile PCR ribotypes, representing an outbreak related
PCR ribotype (027), an endemic PCR ribotype (014) and
a non-toxigenic PCR ribotype (010).
Methods
Compounds tested (Table 1)
Compounds A and D are both cationic surfactants, which
cause membrane damage involving phospholipid bilayers of
the cytoplasmic membrane [12]. Compound B, with a spori-
cidal claim, has hydrogen peroxide as active ingredient.
Hydrogen peroxide kills bacteria by oxidizing their cell walls,
stealing electrons and disrupting their chemical structures
[13]. Hydrogen peroxide wipes are suggested to be sporicidal
and can be used near patients for enhanced cleaning and
disinfection. Compound C is classified as an alcohol, which
denaturizes the proteins rapidly and causes membrane dam-
age, which then interferes with the metabolism and causes
cell lysis [12]. Alcohol is known to be non-sporicidal [12].
Disinfecting cleaning wipes and sprays
Compounds A, B and C were tested in the form of a
wipe, as well as in the form of a spray. Compound D
presently only exists as a spray. All of the sprays and
wipes combine cleaning and disinfection properties.
Wipes and sprays A-C are presently used in healthcare
facilities around Europe, but spray D is not used in
healthcare facilities (Table 1). Wipes A and C are ready
to use, whereas wipe B needs to be prepared according
to the manufacturer’s instructions.
Bacterial strains
C. difficile strains 010, 014 and 027 were obtained from
the Dutch National Reference Laboratory (Type 010
Leeds/Leiden collection; Type 014 Brazier ATCC 43600
and Type 027 Brazier R20291). The strains were grown
48 h at 37 °C on a Brazier agar in an anaerobic chamber.
Brazier medium was chosen since it has spore-
germinating properties [14].
Efficacy of cleaning/disinfectant products to C. difficile
spores
After culturing, the bacterial strains were suspended in
phosphate buffered saline (PBS) and adjusted to a
McFarland standard of 0.5. Vegetative cells were killed by
heating for 20 min at 65 °C in a water bath [15]. To mimic
low and high organic contamination in hospital environ-
ments, spores were suspended in two different test solu-
tions; A and B. Test solutions contained 3% bovine serum
albumin with 0.3% sheep erythrocytes (A) or 12% bovine
serum albumin with 10% sheep erythrocytes (B), to mimic
‘low’ and ‘high’ organic contamination conditions respect-
ively, similarly as applied in a study by Diab-Elschahawi
et al. [16]. All tests were performed in triplicate. As a
positive control three tests were carried out with the
inoculum, but without the decontamination step. For
the negative control sterile water was used instead of the
inoculum and no decontamination step was applied.
Table 1 Disinfecting cleaning wipe and spray ingredients
Wipe/Spray Compositiona Product Sporicidal claim
Wipe and spray A Glucoprotamin 26 g/100 g
(1.5%)
Incidin plus wipes No
Wipe and spray B Hydrogen peroxide (Hispeed H2O2™):
15 mg/g (CAS 77–22-841)
Aseptix Sterimax
Sporicide wipes
Yes
Wipe and spray C Ethanol 140 mg/g,
Propane-2-ol 100 mg/g; Propane-1-ol
60 mg/g, Nalkyl
amino propyl glycine (CAS 1397 34–65-9)
5 mg/g
Bacillol 30 tissues No
Spray D Didecyldimonium
Chloride, Benzalkonium Chloride, Polyaminopropyl,
Biguanide, Dimenthicone
Formula 429 spray Not known
aActive ingredient
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Standardized ceramic tiles (Villeroy & Boch, Art.Nr:3709/
PA00) measuring 5x5cm were used as test surface [16].
Tiles were sterilized for 15 min at 121 °C. The tiles were
contaminated with 0.1 ml of test suspension corresponding
with 5x106CFU/ml spores. The test suspension was spread
with a spatula and dried in the laminar airflow cabinet for
one hour.
A reduction of spores does not necessarily mean that
all spores are killed; it is possible that only growth is
inhibited. Therefore we chose to use two different
methods to test efficiency: adenosine triphosphate (ATP)
to measure reduction of C. difficile and counting colony
forming units (CFUs) to measure killing of C. difficile
spores. ATP was measured before and after tiles under-
went cleaning/disinfection with a wipe or spray. Clean
trace 3 M swabs were used according to the manufac-
turer’s instruction and relative light units (RLU) were
measured in a clean trace NG 3 M luminometer [17].
To measure CFUs, tiles were wiped with a cloth or
sprayed and then wiped with a paper towel. A standard-
ized sweeping technique was used; wiping was per-
formed starting in the left upper corner performing a
meander-like pattern, with 4 turns, ending in the right
lower corner. Tiles were then placed into neutralizer,
consisting of lecithin 3 g/l, L-histidine 1 g/l, saponin
30 g/l in diluent (tryptone, pancreatic digest of casein
1.0 g/l, sodium chloride 8.5 g/l). After 2 min in the
neutralizer (10 ml) and 3 min of horizontal shaking
(150 rpm) with glass beads (15 g; 5 mm) an aliquot of
the suspension (0.1 ml) was plated on Brazier’s agar.
CFUs were counted after 48 h of incubation at 37 °C on
Brazier’s agar in an anaerobic chamber.
Statistical analysis
The log reduction was defined as the logarithm with
base 10 of the relative reduction of CFUs and RLUs.
Log reductions were summarized using means and
standard deviations. Analysis of variance (ANOVA) was
used with the log reduction of CFUs and RLUs as
dependent variable and bacteria (C. difficile strains be-
longing to PCR ribotypes 010, 014, 027), wipes A-C and
sprays A–D, and level of pollution (3% and 12%) as in-
dependent variables. Two-way interaction effects of
bacteria, spray/wipe, and level of pollution were in-
cluded in the model when statistically significant. The
results of the ANOVA are summarized using the esti-
mated marginal means, which are the predicted values
of the dependent variable (log reduction of CFUs/
RLUs) adjusted for the effects of covariates. Tukey’s
multiple comparisons of means were used to assess the
differences between the different products and bacteria.
All statistical analyses were carried out in R version
3.1.1. (Vienna, Austria) [18], and a two-sided signifi-
cance level of 0.05 was used.
Results
CFU - reduction
The overall CFU reduction was highest for C. difficile
PCR ribotype 010 (log10 4.50, 95% CI 4.37–4.69),
followed by the effect against C. difficile PCR ribotype
027 (log10 3.60, 95% CI 3.44–3.76) and C. difficile PCR
ribotype 014 (log10 3.75, 95% CI 3.59–3.92). The CFU
reduction of the tested products was significantly less
for C. difficile 014 and 027 in comparison to C. difficile
010 (p < 0.001). The marginal estimated mean in log10
CFU reduction per product is shown in Table 2.
Wipe B had the highest log10 CFU reduction of 5.29
(95% CI 5.04–5.54) for the wipes and spray B had the
highest log10 CFU reduction of 4.08 (95% CI 3.83–4.33)
for the sprays. The efficacy between wipe B and spray B
is significantly different (p < 0.001). Wipe B with a 1.5%
hydrogen peroxide concentration was the only product
to reach a 5log10 CFU reduction for all the C. difficile
strains tested. Overall the wipes were more effective
than the sprays with the same active ingredient (all;
p < 0.001).
In the experiment no significant difference in efficacy
of the tested products between test solution A and B
(p = 0.50) was found according to ANOVA.
The estimated marginal mean log10 CFU reductions of
C. difficile for all products and test solutions are shown
in Figs. 1 and 2. Figure 1 demonstrates that wipes B and
spray B were the most effective against all tested PCR
ribotypes. A discrepancy in mean log10 bacterial removal
for wipe B is seen between the two organic contamin-
ation solutions, as wipe B performed better with “high”
organic contamination (B). Figure 2 also shows that in a
high organic contamination environment, wipe B was
especially most effective for ribotype 027.
ATP – reduction
On average the RLU log10 reduction of C. difficile 010 was
1.70 (95% CI 1.65–1.76), for C. difficile 014 1.67 (95% CI
1.61–1.72) and for C. difficile 027 1.64 (95% CI 1.58–1.69).
The tested products had different RLU log10 reduc-
tions (Table 2). The most effective products in removing
Table 2 Mean log10 bacterial load reduction and mean log10
RLU reduction of cleaning/ disinfection products with 95%
confidence intervals (CIs)
Product Log10 CFU reduction Log10 RLU reduction
Wipe A 3.91 (CI 3.66–4.16) 1.86 (CI 1.78–1.94)
Spray A 3.08 (CI 2.83–3.33) 1.67 (CI 1.67–1.84)
Wipe B 5.29 (CI 5.04–5.54) 1.86 (CI 1.77–1.94)
Spray B 4.08 (CI 3.83–4.33) 1.45 (CI 1.36–1.53)
Wipe C 4.69 (CI 4.44–4.94) 1.67 (CI 1.58–1.75)
Spray C 3.09 (CI 2.84–3.34) 1.54 (CI 1.46–1.62)
Spray D 3.59 (CI 3.34–3.84) 1.56 (CI 1.48–1.64)
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Fig. 1 CFU reduction with “low” organic contamination (solution A)Mean log10 bacterial removal from tiles examining efficacy of disinfecting
cleaning wipes and spray with a 3% test soil against 5x106CFU/ml of C. difficile PCR ribotypes 010, 014 and 027. Data are the estimated marginal
mean of 3 triplicates, and bars represent 95% prediction intervals
Fig. 2 CFU reduction with “high” organic contamination (solution B)Mean log10 bacterial removal from tiles examining efficacy of disinfecting
cleaning wipes and spray with a 12% test soil against 5x106CFU/ml of C. difficile PCR ribotypes 010, 014 and 027. Data are the estimated marginal
mean of 3 triplicates, and bars represent 95% prediction intervals
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the test soil were wipes A and B with a RLU log10 reduc-
tion of 1.86 (95% CI 1.77–1.94). For products A and C
no significant difference was found in effectiveness be-
tween the spray and wipe (p = 0.62 and p = 0.36). Prod-
uct B had a significant difference in its effectiveness
between the wipe and spray (p < 0.001).
The RLU log10 reduction differed significantly between
test solutions A and B (p < 0.001), whereas no significant
difference for RLU reduction was seen between the dif-
ferent C. difficile strains (p = 0.16).
The estimated marginal mean of RLU log10 reduction
per bacteria for both test solutions is shown in Figs. 3
and 4. Figure 3 reveals that all wipes (except wipe C)
and sprays had greatest protein removal against ribotype
027. In addition a discrepancy in protein reduction for
C. difficile PCR ribotype 027 between the organic
solutions A and B is shown, the activity of the wipes and
sprays was smaller in the ‘high’ organic solution.
Discussion
CDI is a serious infection, with an all cause 30-day
mortality of 15% or greater, that warrants a variety of
infection control measures to prevent and control its
occurrence [19]. Effective cleaning and disinfection is an
essential prerequisite to prevent the spread of CDI
within healthcare settings. Presently, chlorine-based
products are the mainstay with regard to environmental
disinfection in the Netherlands, but alternative, ready-
to-use products are needed to ensure consistent clean-
ing. We therefore tested the effectiveness of different
cleaning/disinfecting wipes and sprays against spores of
C. difficile PCR ribotypes 010, 014 and 027. These ribo-
types were chosen because of their differences in viru-
lence and transmission potential. C. difficile ribotype 010
does not produce toxins and therefore is unable to cause
CDI in humans. In contrast, C. difficile PCR ribotype
027 is known for its “hypervirulence”. It is associated
with increased morbidity and mortality [15, 20, 21], as
well as its potential to cause large outbreaks. Currently,
this type is found in 1.2% of all characterized isolates
sent to the National Reference Laboratory in the
Netherlands [21]. The third tested strain PCR ribotype
014 produces toxin A and B and is the most prevalent
(17%) PCR ribotype in the Netherlands [21].
The overall effectiveness of products measured by
log10 CFU reductions ranged from 3.09 (spray A) to 5.29
(wipe B). While to date a European standard for an in
vivo test that mimics the real-life situation for sporicidal
effectiveness is missing, the EN 13704 ‘suspension test’
requires a 3 log10 CFU reduction after 60 min. All prod-
ucts, in all application forms, would therefore pass this
European norm. Given the fact that higher numbers of
spores are found in the hospital environment [20] and
that patients with a CDI can excrete up to 1 × 107
spores per gram feces [5], a more realistic EN test
should be developed that mimics real-life bacterial/spore
Fig. 3 RLU reduction with “low” organic contamination (solution A)Mean log10 ATP reduction from tiles examining efficacy of disinfecting-cleaning
wipes and spray with a 3% test soil against 5x106 CFU/ml of C. difficile PCR ribotypes 010, 014 and 027. Data are the estimated marginal mean of 3
triplicates, and bars represent 95% prediction intervals
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loads and cleaning times of less than 60 min. We would
recommend a significantly higher (e.g. a 5 log10) CFU re-
duction for effective control of C. difficile transmission,
as was also proposed by Fraise et al. [20]. Our tests show
that this requirement is feasible, as shown by the fact
that wipe B achieved a 5.29 log10 CFU reduction.
When comparing the mean log10 CFU reductions by
application type (wipe versus spray), it became obvious
that the ready-to-use wipes were outperforming the
sprays using a paper towel by 0.81 to 1.60 log10 CFU
reductions. The differences in log10 CFU reduction
between the wipe and spray with the same active ingre-
dient were consistently observed for all products tested
in both application forms (A, B and C). While not as
pronounced, the differences in log10 CFU reductions
were also apparent in log10 RLU reductions, with the
three highest log10 RLU reductions seen for wipes and
the lowest for sprays. This difference between wipes and
sprays could possibly be explained by the “mechanical”
effect involved with cleaning/disinfecting. Studies similar
to ours, but using detergent wipes achieved an average
log10 CFU reduction of 1.63, which is exactly within the
range of difference we observed with wipes and sprays
[22, 23]. Clearly, the application form is responsible for a
significant part of the effect in addition or combination
with the disinfecting active compound. As we compared
wipes against sprays plus paper towels, some may argue
that the difference in effect is due to the difference in
mechanical effect of the different materials used for
wiping. Based on a study by Diab-Elschahawi et al., who
compared microfibers, cotton cloths, sponge cloths and
paper towels for their decontamination abilities, without
finding a significant difference [16], we conclude that
the difference between wipes and sprays in our study
cannot be explained by the difference in wiping material.
Although sprays were used according to the suppliers’
instructions, surface coverage as well as the actual
contact time and number of wiping movements might
be different to the use of impregnated wipes. Wipes B
and C were available as ready-to-use wipes and wipe A
needed to be prepared in a reusable container. Ready-to-
use wipes eliminate the possibility of human errors that
could make the disinfectant less effective or make the
wipes unnecessarily toxic.
In addition to the application method and the com-
pound used, our results indicate that the individual C.
difficile strain is of importance with regard to the effect
of cleaners/disinfectants. While CFU reductions were
highest for the non-toxin producing C. difficile ribotype
010 in a low organic contamination environment, they
were lower for the clinically more important ribotypes
014 and 027. Interestingly, the differences in effective-
ness were less pronounced and, in the case of wipe B,
even reversed in a high organic contamination environ-
ment. While our results in this regard are not fully
conclusive, they certainly indicate the importance of in-
cluding a variety of clinically relevant ribotypes when
evaluating the effect of disinfectants against C. difficile.
Fig. 4 RLU reduction with “high” organic contamination (solution B)Mean log10 ATP reduction from tiles examining efficacy of disinfecting-cleaning
wipes and spray with a 12% test soil against 5x106CFU/ml of C. difficile PCR ribotypes 010, 014 and 027. Data are the estimated marginal mean of 3
triplicates, and bars represent 95% prediction intervals
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Conclusion
In conclusion C. difficile spores of 014 and 027 strain
are harder to eliminate compared to those of the non-
toxigenic strain 010. Future studies should use these
more resilient types of C. difficile to ensure the needed
in-vivo effect. Impregnated cleaning/disinfection wipes
generally outperform ready-to-use sprays, even if based
on the same active ingredient, and should thus be
preferred over sprays for the daily cleaning/disinfection
in rooms of patients with CDI. While all products pass
current EN 13704 standards we believe that - given the
in-vivo load of Clostridium spores - higher standards
should be set, such as those achieved by the products
based on 1.5% of hydrogen peroxide.
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